ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expenses.
Current stock price: 10.97 pence, up 2.1% on Tuesday in London
12-month change: down 43%
By Heather Rydings; firstname.lastname@example.org
Copyright 2022 Alliance News Limited. All Rights Reserved.